ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
4
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
4
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Invasive Transcranial Stimulation System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-15M17607
Home | Market Reports | Science| Biological Sciences
Global Non Invasive Transcranial Stimulation System Market Research Report 2024
BUY CHAPTERS

Global Non-Invasive Transcranial Stimulation System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-15M17607
Report
October 2025
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Soterix Medical
Brainbox
Flow Neuroscience
NeuroCare Group
Newronika
Neuracle
NeuroCare
Neurolite
lonclinics
Volcan Medical

Non-Invasive Transcranial Stimulation System Market

The global Non-Invasive Transcranial Stimulation System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Non-invasive transcranial stimulation system is a medical device that delivers electrical or magnetic stimulation to specific areas of the brain through the scalp without the need for surgery. This system is used in research and clinical settings to modulate brain activity and treat neurological and psychiatric disorders non-invasively.
From a downstream perspective, Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Non-Invasive Transcranial Stimulation System leading manufacturers including Soterix Medical, Brainbox, Flow Neuroscience, lonclinics, NeuroCare Group, Newronika, Neuracle, Volcan Medical, Neurocare, Neurolite, etc., dominate supply; the top five capture approximately % of global revenue, with Soterix Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Non-Invasive Transcranial Stimulation System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Non-Invasive Transcranial Stimulation System Market Report

Report Metric Details
Report Name Non-Invasive Transcranial Stimulation System Market
Segment by Type
Segment by Application
  • Research
  • Medical
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Soterix Medical, Brainbox, Flow Neuroscience, lonclinics, NeuroCare Group, Newronika, Neuracle, Volcan Medical, Neurocare, Neurolite
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Non-Invasive Transcranial Stimulation System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Non-Invasive Transcranial Stimulation System Market report?

Ans: The main players in the Non-Invasive Transcranial Stimulation System Market are Soterix Medical, Brainbox, Flow Neuroscience, lonclinics, NeuroCare Group, Newronika, Neuracle, Volcan Medical, Neurocare, Neurolite

What are the Application segmentation covered in the Non-Invasive Transcranial Stimulation System Market report?

Ans: The Applications covered in the Non-Invasive Transcranial Stimulation System Market report are Research, Medical, Others

What are the Type segmentation covered in the Non-Invasive Transcranial Stimulation System Market report?

Ans: The Types covered in the Non-Invasive Transcranial Stimulation System Market report are Magnetic Stimulation Type, Electrical Stimulation Type

Recommended Reports

Neurostimulation Devices

Transcranial Stimulation

Non-Invasive Monitoring

1 Study Coverage
1.1 Introduction to Non-Invasive Transcranial Stimulation System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Non-Invasive Transcranial Stimulation System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Magnetic Stimulation Type
1.2.3 Electrical Stimulation Type
1.3 Market Segmentation by Application
1.3.1 Global Non-Invasive Transcranial Stimulation System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Research
1.3.3 Medical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-Invasive Transcranial Stimulation System Revenue Estimates and Forecasts 2020-2031
2.2 Global Non-Invasive Transcranial Stimulation System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Non-Invasive Transcranial Stimulation System Sales Estimates and Forecasts 2020-2031
2.4 Global Non-Invasive Transcranial Stimulation System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Non-Invasive Transcranial Stimulation System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Non-Invasive Transcranial Stimulation System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Magnetic Stimulation Type Market Size by Manufacturers
3.5.2 Electrical Stimulation Type Market Size by Manufacturers
3.6 Global Non-Invasive Transcranial Stimulation System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Non-Invasive Transcranial Stimulation System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Non-Invasive Transcranial Stimulation System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Non-Invasive Transcranial Stimulation System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Non-Invasive Transcranial Stimulation System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Non-Invasive Transcranial Stimulation System Sales and Revenue by Type (2020-2031)
6.4 North America Non-Invasive Transcranial Stimulation System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Non-Invasive Transcranial Stimulation System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Non-Invasive Transcranial Stimulation System Sales and Revenue by Type (2020-2031)
7.4 Europe Non-Invasive Transcranial Stimulation System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Non-Invasive Transcranial Stimulation System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Non-Invasive Transcranial Stimulation System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Non-Invasive Transcranial Stimulation System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Non-Invasive Transcranial Stimulation System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Soterix Medical
11.1.1 Soterix Medical Corporation Information
11.1.2 Soterix Medical Business Overview
11.1.3 Soterix Medical Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.1.4 Soterix Medical Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Soterix Medical Non-Invasive Transcranial Stimulation System Sales by Product in 2024
11.1.6 Soterix Medical Non-Invasive Transcranial Stimulation System Sales by Application in 2024
11.1.7 Soterix Medical Non-Invasive Transcranial Stimulation System Sales by Geographic Area in 2024
11.1.8 Soterix Medical Non-Invasive Transcranial Stimulation System SWOT Analysis
11.1.9 Soterix Medical Recent Developments
11.2 Brainbox
11.2.1 Brainbox Corporation Information
11.2.2 Brainbox Business Overview
11.2.3 Brainbox Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.2.4 Brainbox Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Brainbox Non-Invasive Transcranial Stimulation System Sales by Product in 2024
11.2.6 Brainbox Non-Invasive Transcranial Stimulation System Sales by Application in 2024
11.2.7 Brainbox Non-Invasive Transcranial Stimulation System Sales by Geographic Area in 2024
11.2.8 Brainbox Non-Invasive Transcranial Stimulation System SWOT Analysis
11.2.9 Brainbox Recent Developments
11.3 Flow Neuroscience
11.3.1 Flow Neuroscience Corporation Information
11.3.2 Flow Neuroscience Business Overview
11.3.3 Flow Neuroscience Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.3.4 Flow Neuroscience Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Flow Neuroscience Non-Invasive Transcranial Stimulation System Sales by Product in 2024
11.3.6 Flow Neuroscience Non-Invasive Transcranial Stimulation System Sales by Application in 2024
11.3.7 Flow Neuroscience Non-Invasive Transcranial Stimulation System Sales by Geographic Area in 2024
11.3.8 Flow Neuroscience Non-Invasive Transcranial Stimulation System SWOT Analysis
11.3.9 Flow Neuroscience Recent Developments
11.4 lonclinics
11.4.1 lonclinics Corporation Information
11.4.2 lonclinics Business Overview
11.4.3 lonclinics Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.4.4 lonclinics Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 lonclinics Non-Invasive Transcranial Stimulation System Sales by Product in 2024
11.4.6 lonclinics Non-Invasive Transcranial Stimulation System Sales by Application in 2024
11.4.7 lonclinics Non-Invasive Transcranial Stimulation System Sales by Geographic Area in 2024
11.4.8 lonclinics Non-Invasive Transcranial Stimulation System SWOT Analysis
11.4.9 lonclinics Recent Developments
11.5 NeuroCare Group
11.5.1 NeuroCare Group Corporation Information
11.5.2 NeuroCare Group Business Overview
11.5.3 NeuroCare Group Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.5.4 NeuroCare Group Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 NeuroCare Group Non-Invasive Transcranial Stimulation System Sales by Product in 2024
11.5.6 NeuroCare Group Non-Invasive Transcranial Stimulation System Sales by Application in 2024
11.5.7 NeuroCare Group Non-Invasive Transcranial Stimulation System Sales by Geographic Area in 2024
11.5.8 NeuroCare Group Non-Invasive Transcranial Stimulation System SWOT Analysis
11.5.9 NeuroCare Group Recent Developments
11.6 Newronika
11.6.1 Newronika Corporation Information
11.6.2 Newronika Business Overview
11.6.3 Newronika Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.6.4 Newronika Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Newronika Recent Developments
11.7 Neuracle
11.7.1 Neuracle Corporation Information
11.7.2 Neuracle Business Overview
11.7.3 Neuracle Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.7.4 Neuracle Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Neuracle Recent Developments
11.8 Volcan Medical
11.8.1 Volcan Medical Corporation Information
11.8.2 Volcan Medical Business Overview
11.8.3 Volcan Medical Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.8.4 Volcan Medical Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Volcan Medical Recent Developments
11.9 Neurocare
11.9.1 Neurocare Corporation Information
11.9.2 Neurocare Business Overview
11.9.3 Neurocare Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.9.4 Neurocare Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Neurocare Recent Developments
11.10 Neurolite
11.10.1 Neurolite Corporation Information
11.10.2 Neurolite Business Overview
11.10.3 Neurolite Non-Invasive Transcranial Stimulation System Product Models, Descriptions and Specifications
11.10.4 Neurolite Non-Invasive Transcranial Stimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Neurolite Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Non-Invasive Transcranial Stimulation System Industry Chain
12.2 Non-Invasive Transcranial Stimulation System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Non-Invasive Transcranial Stimulation System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Non-Invasive Transcranial Stimulation System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Non-Invasive Transcranial Stimulation System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Non-Invasive Transcranial Stimulation System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Soterix Medical
Brainbox
Flow Neuroscience
NeuroCare Group
Newronika
Neuracle
NeuroCare
Neurolite
lonclinics
Volcan Medical
List of Tables
 Table 1. Global Non-Invasive Transcranial Stimulation System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Non-Invasive Transcranial Stimulation System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Non-Invasive Transcranial Stimulation System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Non-Invasive Transcranial Stimulation System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Non-Invasive Transcranial Stimulation System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Non-Invasive Transcranial Stimulation System Sales by Region (2020-2025) & (Units)
 Table 8. Global Non-Invasive Transcranial Stimulation System Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Non-Invasive Transcranial Stimulation System Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Non-Invasive Transcranial Stimulation System Sales Share by Manufacturers (2020-2025)
 Table 12. Global Non-Invasive Transcranial Stimulation System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Non-Invasive Transcranial Stimulation System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Non-Invasive Transcranial Stimulation System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Transcranial Stimulation System as of 2024)
 Table 16. Global Non-Invasive Transcranial Stimulation System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Non-Invasive Transcranial Stimulation System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Non-Invasive Transcranial Stimulation System Manufacturing Base and Headquarters
 Table 19. Global Non-Invasive Transcranial Stimulation System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Non-Invasive Transcranial Stimulation System Sales by Type (2020-2025) & (Units)
 Table 23. Global Non-Invasive Transcranial Stimulation System Sales by Type (2026-2031) & (Units)
 Table 24. Global Non-Invasive Transcranial Stimulation System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Non-Invasive Transcranial Stimulation System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Non-Invasive Transcranial Stimulation System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Non-Invasive Transcranial Stimulation System Sales by Application (2020-2025) & (Units)
 Table 29. Global Non-Invasive Transcranial Stimulation System Sales by Application (2026-2031) & (Units)
 Table 30. Non-Invasive Transcranial Stimulation System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Non-Invasive Transcranial Stimulation System Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Non-Invasive Transcranial Stimulation System Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Non-Invasive Transcranial Stimulation System ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Non-Invasive Transcranial Stimulation System Growth Accelerators and Market Barriers
 Table 37. North America Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Non-Invasive Transcranial Stimulation System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Non-Invasive Transcranial Stimulation System Growth Accelerators and Market Barriers
 Table 40. Europe Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Non-Invasive Transcranial Stimulation System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Non-Invasive Transcranial Stimulation System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Non-Invasive Transcranial Stimulation System Investment Opportunities and Key Challenges
 Table 47. Central and South America Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Non-Invasive Transcranial Stimulation System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Non-Invasive Transcranial Stimulation System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Soterix Medical Corporation Information
 Table 51. Soterix Medical Description and Major Businesses
 Table 52. Soterix Medical Product Models, Descriptions and Specifications
 Table 53. Soterix Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Soterix Medical Sales Value Proportion by Product in 2024
 Table 55. Soterix Medical Sales Value Proportion by Application in 2024
 Table 56. Soterix Medical Sales Value Proportion by Geographic Area in 2024
 Table 57. Soterix Medical Non-Invasive Transcranial Stimulation System SWOT Analysis
 Table 58. Soterix Medical Recent Developments
 Table 59. Brainbox Corporation Information
 Table 60. Brainbox Description and Major Businesses
 Table 61. Brainbox Product Models, Descriptions and Specifications
 Table 62. Brainbox Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Brainbox Sales Value Proportion by Product in 2024
 Table 64. Brainbox Sales Value Proportion by Application in 2024
 Table 65. Brainbox Sales Value Proportion by Geographic Area in 2024
 Table 66. Brainbox Non-Invasive Transcranial Stimulation System SWOT Analysis
 Table 67. Brainbox Recent Developments
 Table 68. Flow Neuroscience Corporation Information
 Table 69. Flow Neuroscience Description and Major Businesses
 Table 70. Flow Neuroscience Product Models, Descriptions and Specifications
 Table 71. Flow Neuroscience Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Flow Neuroscience Sales Value Proportion by Product in 2024
 Table 73. Flow Neuroscience Sales Value Proportion by Application in 2024
 Table 74. Flow Neuroscience Sales Value Proportion by Geographic Area in 2024
 Table 75. Flow Neuroscience Non-Invasive Transcranial Stimulation System SWOT Analysis
 Table 76. Flow Neuroscience Recent Developments
 Table 77. lonclinics Corporation Information
 Table 78. lonclinics Description and Major Businesses
 Table 79. lonclinics Product Models, Descriptions and Specifications
 Table 80. lonclinics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. lonclinics Sales Value Proportion by Product in 2024
 Table 82. lonclinics Sales Value Proportion by Application in 2024
 Table 83. lonclinics Sales Value Proportion by Geographic Area in 2024
 Table 84. lonclinics Non-Invasive Transcranial Stimulation System SWOT Analysis
 Table 85. lonclinics Recent Developments
 Table 86. NeuroCare Group Corporation Information
 Table 87. NeuroCare Group Description and Major Businesses
 Table 88. NeuroCare Group Product Models, Descriptions and Specifications
 Table 89. NeuroCare Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. NeuroCare Group Sales Value Proportion by Product in 2024
 Table 91. NeuroCare Group Sales Value Proportion by Application in 2024
 Table 92. NeuroCare Group Sales Value Proportion by Geographic Area in 2024
 Table 93. NeuroCare Group Non-Invasive Transcranial Stimulation System SWOT Analysis
 Table 94. NeuroCare Group Recent Developments
 Table 95. Newronika Corporation Information
 Table 96. Newronika Description and Major Businesses
 Table 97. Newronika Product Models, Descriptions and Specifications
 Table 98. Newronika Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Newronika Recent Developments
 Table 100. Neuracle Corporation Information
 Table 101. Neuracle Description and Major Businesses
 Table 102. Neuracle Product Models, Descriptions and Specifications
 Table 103. Neuracle Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Neuracle Recent Developments
 Table 105. Volcan Medical Corporation Information
 Table 106. Volcan Medical Description and Major Businesses
 Table 107. Volcan Medical Product Models, Descriptions and Specifications
 Table 108. Volcan Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Volcan Medical Recent Developments
 Table 110. Neurocare Corporation Information
 Table 111. Neurocare Description and Major Businesses
 Table 112. Neurocare Product Models, Descriptions and Specifications
 Table 113. Neurocare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Neurocare Recent Developments
 Table 115. Neurolite Corporation Information
 Table 116. Neurolite Description and Major Businesses
 Table 117. Neurolite Product Models, Descriptions and Specifications
 Table 118. Neurolite Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Neurolite Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Non-Invasive Transcranial Stimulation System Product Picture
 Figure 2. Global Non-Invasive Transcranial Stimulation System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Magnetic Stimulation Type Product Picture
 Figure 4. Electrical Stimulation Type Product Picture
 Figure 5. Global Non-Invasive Transcranial Stimulation System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Research
 Figure 7. Medical
 Figure 8. Others
 Figure 9. Non-Invasive Transcranial Stimulation System Report Years Considered
 Figure 10. Global Non-Invasive Transcranial Stimulation System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Non-Invasive Transcranial Stimulation System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Non-Invasive Transcranial Stimulation System Revenue Market Share by Region (2020-2031)
 Figure 14. Global Non-Invasive Transcranial Stimulation System Sales (2020-2031) & (Units)
 Figure 15. Global Non-Invasive Transcranial Stimulation System Sales (CAGR) by Region (2020-2031) (Units)
 Figure 16. Global Non-Invasive Transcranial Stimulation System Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Non-Invasive Transcranial Stimulation System Sales Volume Market Share in 2024
 Figure 18. Global Non-Invasive Transcranial Stimulation System Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Magnetic Stimulation Type Revenue Market Share by Manufacturer in 2024
 Figure 21. Electrical Stimulation Type Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Non-Invasive Transcranial Stimulation System Sales Market Share by Type (2020-2031)
 Figure 23. Global Non-Invasive Transcranial Stimulation System Revenue Market Share by Type (2020-2031)
 Figure 24. Global Non-Invasive Transcranial Stimulation System Sales Market Share by Application (2020-2031)
 Figure 25. Global Non-Invasive Transcranial Stimulation System Revenue Market Share by Application (2020-2031)
 Figure 26. North America Non-Invasive Transcranial Stimulation System Sales YoY (2020-2031) & (Units)
 Figure 27. North America Non-Invasive Transcranial Stimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) in 2024
 Figure 29. North America Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Type (2020- 2031)
 Figure 30. North America Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Application (2020-2031)
 Figure 32. North America Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Non-Invasive Transcranial Stimulation System Sales YoY (2020-2031) & (Units)
 Figure 37. Europe Non-Invasive Transcranial Stimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Type (2020-2031)
 Figure 40. Europe Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Application (2020-2031)
 Figure 42. Europe Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 44. France Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales YoY (2020-2031) & (Units)
 Figure 49. Asia-Pacific Non-Invasive Transcranial Stimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 59. India Non-Invasive Transcranial Stimulation System Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Non-Invasive Transcranial Stimulation System Sales YoY (2020-2031) & (Units)
 Figure 61. Central and South America Non-Invasive Transcranial Stimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Type (2021-2031)
 Figure 64. Central and South America Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Application (2020-2031)
 Figure 66. Central and South America Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Non-Invasive Transcranial Stimulation System Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Non-Invasive Transcranial Stimulation System Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Non-Invasive Transcranial Stimulation System Sales YoY (2020-2031) & (Units)
 Figure 70. Middle East and Africa Non-Invasive Transcranial Stimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Type (2021-2031)
 Figure 73. South America Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Volume (Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Non-Invasive Transcranial Stimulation System Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Non-Invasive Transcranial Stimulation System Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Non-Invasive Transcranial Stimulation System Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Non-Invasive Transcranial Stimulation System Revenue (2020-2025) & (US$ Million)
 Figure 80. Non-Invasive Transcranial Stimulation System Industry Chain Mapping
 Figure 81. Regional Non-Invasive Transcranial Stimulation System Manufacturing Base Distribution (%)
 Figure 82. Global Non-Invasive Transcranial Stimulation System Production Market Share by Region (2020-2031)
 Figure 83. Non-Invasive Transcranial Stimulation System Production Process
 Figure 84. Regional Non-Invasive Transcranial Stimulation System Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Non invasive Brain Stimulation System Market Research Report 2024
Global Transcranial Magnetic Stimulation TMS System Market Research Report 2025
Global Transcranial Electrical Stimulation Market Research Report 2025
Global Transcranial Electrical Stimulation tES Devices Market Research Report 2024
Global Transcranial Direct Current Stimulation tDCS Devices Market Research Report 2024
Global Transcranial Electrical Stimulators Market Research Report 2025
Global Non invasive Neuromodulation Device Market Research Report 2024
Non Invasive Neuromodulatory Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcranial Magnetic Stimulation Treatment Market Research Report 2025
Global Non Invasive Ultrasound Stimulation Market Research Report 2024
Global Transcranial Magnetic Stimulators TMS Market Research Report 2025
Global Medical Transcranial Magnetic Stimulator Market Research Report 2024
Global Transcranial DC Stimulator Market Research Report 2024
Global Transcranial Magnetic Stimulation Treatment Devices Market Research Report 2025
Global Transcranial Direct Current Stimulation Systems Market Research Report 2024
Global Implantable Neurostimulation System Market Research Report 2024
Transcranial Stimulator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Neurofeedback Device Market Research Report 2024
Global Non Invasive Brain Computer Interface Device Market Research Report 2024
Global Paired pulse Transcranial Magnetic Stimulator Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions